CL2014002583A1 - Aglomerados de nanopartículas que contiene osteopontina y partículas que contiene calcio y/o estroncio. - Google Patents

Aglomerados de nanopartículas que contiene osteopontina y partículas que contiene calcio y/o estroncio.

Info

Publication number
CL2014002583A1
CL2014002583A1 CL2014002583A CL2014002583A CL2014002583A1 CL 2014002583 A1 CL2014002583 A1 CL 2014002583A1 CL 2014002583 A CL2014002583 A CL 2014002583A CL 2014002583 A CL2014002583 A CL 2014002583A CL 2014002583 A1 CL2014002583 A1 CL 2014002583A1
Authority
CL
Chile
Prior art keywords
agglomerates
strontium
osteopontin
nanoparticles
particles containing
Prior art date
Application number
CL2014002583A
Other languages
English (en)
Spanish (es)
Inventor
Peter Langborg Wejse
Henrik Birkedal
Jakob Olsen
Jonas Skovgaard
Sebastian Schlafer
Rikke Louise Meyer
Bente Nyvad
Dunca Stewart Sutherland
Original Assignee
Arla Foods Amba
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arla Foods Amba filed Critical Arla Foods Amba
Publication of CL2014002583A1 publication Critical patent/CL2014002583A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A61K8/0275—Containing agglomerated particulates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Physiology (AREA)
  • Dispersion Chemistry (AREA)
  • Nutrition Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
CL2014002583A 2012-03-28 2014-09-26 Aglomerados de nanopartículas que contiene osteopontina y partículas que contiene calcio y/o estroncio. CL2014002583A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP12161802 2012-03-28

Publications (1)

Publication Number Publication Date
CL2014002583A1 true CL2014002583A1 (es) 2015-06-12

Family

ID=48141914

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2014002583A CL2014002583A1 (es) 2012-03-28 2014-09-26 Aglomerados de nanopartículas que contiene osteopontina y partículas que contiene calcio y/o estroncio.

Country Status (13)

Country Link
US (2) US20150044260A1 (cg-RX-API-DMAC7.html)
EP (1) EP2830647A1 (cg-RX-API-DMAC7.html)
JP (1) JP2015516949A (cg-RX-API-DMAC7.html)
KR (1) KR20150004814A (cg-RX-API-DMAC7.html)
CN (1) CN104321073A (cg-RX-API-DMAC7.html)
AR (1) AR090569A1 (cg-RX-API-DMAC7.html)
AU (1) AU2013241750A1 (cg-RX-API-DMAC7.html)
CA (1) CA2868684A1 (cg-RX-API-DMAC7.html)
CL (1) CL2014002583A1 (cg-RX-API-DMAC7.html)
EA (1) EA201491691A1 (cg-RX-API-DMAC7.html)
MX (1) MX2014011594A (cg-RX-API-DMAC7.html)
NZ (1) NZ700295A (cg-RX-API-DMAC7.html)
WO (1) WO2013144247A1 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0811530B1 (pt) 2007-05-14 2019-01-02 Research Foundation Of State Univ Of New York composição compreendendo indutor(es) de resposta fisiológica à dispersão ácido decanóico, superfície, solução, método ex vivo de tratamento ou inibição da formação de um biofilme sobre uma superfície
US12109284B2 (en) 2016-11-08 2024-10-08 Dentherapy Ltd Compositions comprising fluoride and calcium and method for preparing them
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
WO2020197887A1 (en) * 2019-03-22 2020-10-01 The Board Of Regents Of The University Of Oklahoma Surface-modified doped titanium dioxide nanoparticles and uses
CN111366733B (zh) * 2020-03-07 2022-02-08 浙江大学 骨桥蛋白作为靶分子在调节肠道菌群定植中的应用
JPWO2021193398A1 (cg-RX-API-DMAC7.html) * 2020-03-27 2021-09-30
GB202010987D0 (en) 2020-07-16 2020-09-02 Dentherapy Ltd Oral care compositions and methods
GB202110114D0 (en) 2021-07-14 2021-08-25 Dentherapy Ltd Oral care compositions for use in treaatment
WO2023187028A1 (en) * 2022-03-31 2023-10-05 Nadavia Holding Aps Mouthwash composition comprising one or more strontium salt
WO2025008636A1 (en) 2023-07-06 2025-01-09 Dentherapy Ltd Oral care compositions for use in the treatment of dental health conditions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7259243B2 (en) * 2000-01-07 2007-08-21 Arla Foods Amba Process for isolation of osteopontin from milk
NZ507335A (en) 2000-10-05 2004-10-29 New Zealand Dairy Board Bone health compositions derived from milk comprising an acidic protein fraction but that does not contain CGMP
AU2004294673B2 (en) * 2003-12-01 2010-05-20 Arla Foods Amba Use of osteopontin in dental formulations
CA2632876A1 (en) * 2005-12-16 2007-06-21 Arla Foods Amba Bovine osteopontin formulations for the improvement of the wound healing process
WO2009010071A1 (en) * 2007-07-16 2009-01-22 Aarhus Universitet Osteopontin nanoparticles system for drug delivery
AU2012222312B2 (en) 2011-03-03 2017-06-08 Arla Foods Amba Method for isolating osteopontin using feeds containing cmp or casein species

Also Published As

Publication number Publication date
US20170065673A1 (en) 2017-03-09
CA2868684A1 (en) 2013-10-03
AR090569A1 (es) 2014-11-19
CN104321073A (zh) 2015-01-28
EA201491691A1 (ru) 2015-04-30
KR20150004814A (ko) 2015-01-13
EP2830647A1 (en) 2015-02-04
MX2014011594A (es) 2015-07-06
AU2013241750A8 (en) 2014-10-23
NZ700295A (en) 2016-07-29
JP2015516949A (ja) 2015-06-18
US20150044260A1 (en) 2015-02-12
AU2013241750A1 (en) 2014-10-09
WO2013144247A1 (en) 2013-10-03

Similar Documents

Publication Publication Date Title
IL256716A (en) Antibodies against hla–b*27 and their uses
EP2864238A4 (en) KOVALENT BONDED GRAPHIC COATING AND APPLICATIONS THEREOF
EP3919056C0 (en) COMPOUNDS AND THEIR USES FOR HEMOGLOBIN MODULATION
EP2927281A4 (en) RESIN COMPOSITION AND USE THEREOF
EP2964022A4 (en) ANALGIC COMBINATION AND USE
SG11201508593QA (en) Novel polymer and thermosetting composition containing same
EP2959031A4 (en) Coatings and composites including inorganic fullerene-like particles and inorganic tubular-like particles
SG11201408545RA (en) Polymer particles and use thereof
CL2015001121A1 (es) Recipiente codificado con partículas
SG11201505411RA (en) Microdevices for separation of non-spherical particles and applications thereof
PL2872569T3 (pl) Minerały zawierające modyfikowany powierzchniowo wąglan wapnia i ich zastosowanie
EP2832695A4 (en) FINE HYDROTALCITE PARTICLES
HRP20170145T1 (hr) Čestice koje sadrže epidermalni faktor rasta i supstancije koje sadrže isti
SG11201508122UA (en) Organic phosphor-functionalized nanoparticles and compositions comprising the same
PL3065732T3 (pl) Związki, kompozycje i odpowiednie zastosowania do zapobiegania i/lub leczenia dyslipidemii
EP2978919A4 (en) METHOD FOR REDUCING THE LIABILITY OF A BITUMENOUS MATERIAL USING NANOPARTICLES
PL2969028T3 (pl) Kompozycje z alkiloamidotiazoli i substancji absorbujących promieniowanie uv
PL3075751T3 (pl) Polimer zawierający grupę karboksylową oraz jego zastosowanie
PT2984228T (pt) Elemento de segurança multi-luminescente e produto de valor ou produto de segurança contendo tal elemento de segurança
IL240248A0 (en) Met-binding agents and uses thereof
EP2920588A4 (en) TRACER PARTICLES AND METHOD FOR THE MANUFACTURE THEREOF
IL241398A0 (en) A device made of biodegradable polymer and its use to create new bone tissue
SG11201508453YA (en) Pharmaceutical composition and uses thereof
DK3344663T3 (da) Penflufenhholdige polymerpartikler
GB201315195D0 (en) Identifying presence of substances